Luspatercept vs. Sotatercept

  • 3 Replies
  • 6840 Views
*

Offline CrazyPharm

  • **
  • 44
  • Gender: Male
Luspatercept vs. Sotatercept
« on: December 22, 2014, 10:51:44 AM »
Can anyone highlight the differences between Sotatercept and Luspatercept. Apparently Acceleron and Celgene will most likely be moving forward with only one of these drugs? does anyone have some info. on this?

Also, their phase II trial in Thalassemia received funding from Novartis. Confused but how does Novartis tie into this? I know Dr. Piga has worked with them but aside from that...bluntly speaking: what's in it for them? :huh

*

Offline Andy Battaglia

  • *****
  • 8793
  • Gender: Male
  • Will thal rule you or will you rule thal?
Re: Luspatercept vs. Sotatercept
« Reply #1 on: December 22, 2014, 03:37:10 PM »
Contrary to popular perception, it is far more likely for a company like Novartis to buy a company for an already developing drug, than to develop one themselves. I would say Novartis has a potential future financial interest.
Andy

All we are saying is give thals a chance.

*

Offline CrazyPharm

  • **
  • 44
  • Gender: Male
Re: Luspatercept vs. Sotatercept
« Reply #2 on: December 22, 2014, 04:11:07 PM »
Thanks Andy, my thoughts exactly! Novartis seems to jump on Thalassemia drugs. On a different note: any idea when the Brand patent on Exjade expires?

*

Offline ama

  • *
  • 19
Re: Luspatercept vs. Sotatercept
« Reply #3 on: December 22, 2014, 08:13:14 PM »
Exjade Patent is supposed to expire on April 5, 2019.

 

SMF spam blocked by CleanTalk